ANEB - Anebulo Pharmaceuticals

-

$undefined

N/A

(N/A)

Anebulo Pharmaceuticals NasdaqCM:ANEB Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.

Location: 1017 Ranch Road 620 South, Lakeway, TX, 78734, United States | Website: https://www.anebulo.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

29.63M

Cash

13.28M

Avg Qtr Burn

-1.688M

Short % of Float

1.00%

Insider Ownership

40.54%

Institutional Own.

55.05%

Qtr Updated

03/31/25